GH Research (GHRS) Non-Current Assets (2021 - 2025)

GH Research's (GHRS) quarterly Non-Current Assets came in at $2.3 million in Q4 2025, down 93.38% year-on-year from $34.0 million in Q4 2024, and down 68.83% quarter-over-quarter from $7.2 million in Q3 2025.

GH Research (GHRS) Non-Current Assets (2021 - 2025) Analysis & Trends

GH Research's Non-Current Assets history runs 5 years deep, the most recent figure standing at $2.3 million for Q4 2025.

  • On a quarterly basis, Non-Current Assets fell 93.38% year-over-year to $2.3 million in Q4 2025; TTM through Dec 2025 was $54.8 million, a 71.13% decrease from a year earlier, with the FY2025 full-year figure at $2.3 million, down 93.38% from the prior year.
  • Non-Current Assets slipped to $2.3 million in Q4 2025 per GHRS's latest filing, from $7.2 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $122.1 million in Q4 2021 and bottomed at $73000.0 in Q3 2021.
  • The 5-year median for Non-Current Assets is $39.4 million (2024), against an average of $41.2 million.
  • Across the five-year window, Non-Current Assets surged 104272.84% in 2023 and tumbled 93.38% in 2025, its largest moves.
  • Year by year, Non-Current Assets stood at $122.1 million in 2021, then decreased by 29.7% to $85.8 million in 2022, then decreased by 27.51% to $62.2 million in 2023, then slumped by 45.27% to $34.0 million in 2024, then tumbled by 93.38% to $2.3 million in 2025.
  • Per Business Quant, the three latest GHRS Non-Current Assets figures stand at $2.3 million (Q4 2025), $7.2 million (Q3 2025), and $19.5 million (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 21.65 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 5.83 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.95 Bn
4 NuCana 279.75 Bn 279.75 Bn - 3.95 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 14.75 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 22.66 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 289.41 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.96 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 285.82 Mn
10 GH Research 1.69 Bn 1.69 Bn - 2.25 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 2.25 Mn
Sep 30, 2025 7.23 Mn
Jun 30, 2025 19.55 Mn
Mar 31, 2025 25.79 Mn
Dec 31, 2024 34.05 Mn
Sep 30, 2024 44.67 Mn
Jun 30, 2024 54.07 Mn
Mar 31, 2024 57.11 Mn
Dec 31, 2023 62.21 Mn
Sep 30, 2023 68.53 Mn
Jun 30, 2023 73.87 Mn
Mar 31, 2023 84.54 Mn
Dec 31, 2022 85.82 Mn
Sep 30, 2022 84,000.00
Jun 30, 2022 86,000.00
Mar 31, 2022 81,000.00
Dec 31, 2021 122.08 Mn
Sep 30, 2021 73,000.00